Diabetic neuropathies: a statement by the American Diabetes Association.

By A. Boulton, A. I. Vinik, J. Arezzo, V. Bril, Eva L. Feldman, R. Freeman, R. Malik, R. Maser, J. Sosenko, Dan Ziegler. Diabetes Care, 2005

2,046 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Neurology, Physiology

View Paper: https://www.semanticscholar.org/paper/a6d35d1c1bffeaca342a6d655eaa4e5741b02b1b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Silvio E. Inzucchi
2. I. Hirsch
3. M. S. Kirkman
4. A. Classification
5. V. Basevi

In Neurology

1. Dan Ziegler
2. A. Vinik

In Physiology

1. Silvio E. Inzucchi
2. A. Classification

Citations in the corpus

• Diabetic Cardiovascular Autonomic Neuropathy (2007, background): “Typically, autonomic labs will combine tilt-table and other studies with HRV measures obtained during deep breathing and Valsalva.85 Other functional syndromes may also be revealed, such as the vasoconstrictor syndrome (paradoxic orthostatic hypertensive syndrome, also known as orthostatic hypertens”
• Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management (2011, background): “The need to use several tests of both vagal and sympathetic functions is reaffirmed in the available guidelines [1,3].”
• Standards of Medical Care in Diabetes—2008 (2008, background): “Interventions for other manifestations of autonomic neuropathy are described in the ADA statement on neuropathy (231).”
• Standards of Medical Care in Diabetes–2006 (2006, neutral): “Neuropathy screening and treatment (174,175)”
• Standards of Medical Care in Diabetes—2009 (2009, background): “Neuropathy screening and treatment (270)”